Barack Obama Says He Would Have Beaten Donald Trump

December 27, 2016

Washington, Dec 27: President Barack Obama said in an interview released Monday that he could have beaten Republican presidential nominee Donald Trump "if I had run again."

obamaIn his most pointed critique yet, Obama said Hillary Clinton's campaign acted too cautiously out of a mistaken belief that victory was all but certain.

"If you think you're winning, then you have a tendency, just like in sports, maybe to play it safer," Obama said in the interview with former adviser and longtime friend David Axelrod, a CNN analyst, for his "The Axe Files" podcast.

The president said Clinton "understandably . . . looked and said, well, given my opponent and the things he's saying and what he's doing, we should focus on that."

Trump took exception to this critique, tweeting out later in the day that "President Obama said that he thinks he would have won against me. He should say that but I say NO WAY! - jobs leaving, ISIS, OCare, etc."

Obama stressed his admiration for Clinton and said she had been the victim of unfair attacks. But, as he has in other exit interviews, Obama insisted that her defeat was not a rejection of the eight years of his presidency. To the contrary, he argued that he had put together a winning coalition that stretched across the country but that the Democratic Party and the Clinton campaign had failed to follow through on it.

"I am confident in this vision because I'm confident that if I - if I had run again and articulated it - I think I could've mobilized a majority of the American people to rally behind it," the president said.

"See, I think the issue was less that Democrats have somehow abandoned the white working class, I think that's nonsense," Obama said. "Look, the Affordable Care Act benefits a huge number of Trump voters. There are a lot of folks in places like West Virginia or Kentucky who didn't vote for Hillary, didn't vote for me, but are being helped by this . . . The problem is, is that we're not there on the ground communicating not only the dry policy aspects of this, but that we care about these communities, that we're bleeding for these communities."

Clinton spokesman Brian Fallon said via email that the campaign declined to comment.

Axelrod, in an interview with The Washington Post, said he believed Obama went further than he had before in critiquing Clinton's campaign.

"This was all in service of making the point that he believes that his progressive vision and the vision he ran on is still a majority view in this country," Axelrod said. "He chooses to be hopeful about the future."

Obama could not have run again; the 22nd Amendment of the Constitution states that "No person shall be elected to the office of the President more than twice."

Still, Obama's suggestion that he could have won if he ran stoked debate Monday among political observers.

Former House speaker Newt Gingrich, a Republican who has been an adviser to Trump, said in an interview that "Obama doesn't know and neither does anyone else. Obama would have increased the turnout in the African American community, but he also might have increased the repudiation of him among those who felt they were betrayed.

"All of the lies he told about Obamacare, 'keeping your doctor' . . . would have come back to haunt him. It would have been a totally different race."

Steve Hildebrand, a Democrat who oversaw Obama's 2008 campaign in battleground states, said the president had an ability to communicate with lower-income workers that Clinton lacked. He said he sent the Clinton campaign 15 emails in which he said he told them "you are not communicating with lower-income workers, you are not connecting with them."

In the podcast interview, Axelrod did not press Obama on many of the most controversial parts of his presidency, such as not taking action to prevent the deaths of hundreds of thousands of people in Syria.

The president, who has done relatively few interviews with mainstream media organizations, repeated his long-stated complaint that the media has filtered his message and that he is subject to unfair criticism by outlets such as Fox News.

Obama also blamed some of his problems during his presidency on Senate Majority Leader Mitch McConnell, R-Ky., a longtime adversary who famously said in 2010: "The single most important thing we want to achieve is for President Obama to be a one-term president."

McConnell failed in that goal, but Obama said the senator was successful in blocking many of his initiatives and setting the groundwork for Trump's victory.

McConnell's strategy from a "tactical perspective was pretty smart and well executed," the president said. The Republican leader found ways to "just throw sand in the gears" in a manner that fed into people's beliefs that things were going badly. Obama said that, as a result, Republicans blocked action that could have helped more people recover from the Great Recession.

The strategy, Obama maintained, was that "if we just say no, then that will puncture the balloon, that all this talk about hope and change and no red state and blue state is - is proven to be a mirage, a fantasy. And if we can - if we can puncture that vision, then we have a chance to win back seats in the House."

A McConnell spokesman did not respond to a request for comment.

Obama stressed that he doesn't plan to get involved in day-to-day responses to a Trump presidency, just as former president George W. Bush has remained mostly on the sidelines during the Obama years. But Obama made it clear that he will be more of an activist in the long run. He said he plans to help mobilize and train a younger generation of Democratic leaders and will speak out if his core beliefs are challenged. He also said he is working on writing a book.

His post-presidential "long-term interest," Obama said, is "to build that next generation of leadership; organizers, journalists, politicians. I see them in America, I see them around the world - 20-year-olds, 30-year-olds who are just full of talent, full of idealism. And the question is how do we link them up? How do we give them the tools for them to bring about progressive change? And I want to use my presidential center as a mechanism for developing that next generation of talent." He said he didn't want to be someone "who's just hanging around reliving old glories."

Obama in the interview also reflected on his years at college, particularly Columbia University, from which he graduated in 1983. He said he was rereading "old journals" and letters to girls that he was "courting," and found them unreadable. He found himself to be "wildly pretentious," recalling how he begged off going to parties so he could read the French philosopher Jean-Paul Sartre. The women on campus found him "too intense," he said.

Looking back, said the president of the United States, "I should've tried, like, you know, 'Wanna go to a movie?' "

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
Agencies
May 26,2020

UN, May 26: Countries could see a "second peak" of coronavirus cases during the first wave of the pandemic if lockdown restrictions were lifted too soon, the World Health Organization (WHO) has warned.

Mike Ryan, the WHO's head of emergencies, told a briefing on Monday that the world was "right in the middle of the first wave", the BBC reported.

He said because the disease was "still on the way up", countries need to be aware that "the disease can jump up at any time".

"We cannot make assumptions that just because the disease is on the way down now that it's going to keep going down," Ryan said.

There would be a number of months to prepare for a second peak, he added.

The stark warning comes as countries around the world start to gradually ease lockdown restrictions, allowing shops to reopen and larger groups of people to gather.

Experts have said that without a vaccine to give people immunity, infections could increase again when social-distancing measures are relaxed.

Ryan said countries where cases are declining should be using this time to develop effective trace-and-test regimes to "ensure that we continue on a downwards trajectory and we don't have an immediate second peak".

Also on Monday, Tedros Adhanom Ghebreyesus, WHO Director-General, said that a clinical trial of hydroxychloroquine (HCQ) on COVID-19 patients has come to "a temporary pause", while the safety data of the the anti-malaria drug was being reviewed.

According to the WHO chief, The Lancet medical journal on May 22 had published an observational study on HCQ and chloroquine and its effects on COVID-19 patients that have been hospitalized, reports Xinhua news agency.

The authors of the study reported that among patients receiving the drug, when used alone or with a macrolide, they estimated a higher mortality rate.

"The Executive Group of the Solidarity Trial, representing 10 of the participating countries, met on Saturday (May 23) and has agreed to review a comprehensive analysis and critical appraisal of all evidence available globally," Tedros said in a virtual press conference.

The developments come as the total number of global COVID-19 cases has increased to 5,508,904, with 346,508 deaths, according to the Johns Hopkins University.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
June 8,2020

Wellington, Jun 8: New Zealand lifted all domestic coronavirus restrictions on Monday after its final COVID-19 patient was given the all clear, with Prime Minister Jacinda Ardern revealing she danced around her living room when told about the milestone.

While strict border controls will remain in place, Ardern said restrictions such as social distancing and limits on public gatherings were no longer needed.

"We are confident we have eliminated transmission of the virus in New Zealand for now," she said in a televised address, saying Kiwis had "united in unprecedented ways to crush the virus".

The South Pacific nation, with a population of five million, has had 1,154 confirmed COVID-19 cases and 22 deaths.

There have been no new infections for 17 days and, until Monday, just one active case for more than a week.

Details of the final patient were not released for privacy reasons but it is believed to be a woman aged in her 50s who was linked to a cluster at an Auckland nursing home.

Ardern said the sacrifices made by New Zealanders, including a drastic seven-week lockdown that helped curb infection rates, had been rewarded now that there were no active cases in the country.

Asked about her reaction upon hearing the news, she replied: "I did a little dance" with baby daughter Neve.

"She was caught a little by surprise but she joined in, having absolutely no idea why I was dancing around the lounge."

New Zealand's move down to Level 1, the lowest rating on its four-tier virus response system, means nightclubs can operate without dance floor restrictions and theatres will reopen.

It also means sporting events can proceed with crowds in the stands, a change New Zealand Rugby (NZR) said offered its Super Rugby Aotearoa competition the opportunity to achieve a world first when it kicks off this weekend.

"We're incredibly proud, and grateful, to be the first professional sports competition in the world to be in a position to have our teams play in front of their fans again," NZR chief executive Mark Robinson said.

While many other sporting competitions around the globe have announced plans to restart, the vast majority will be played either with no crowds or with numbers severely restricted.

On a broader level, Ardern said easing restrictions would help New Zealand's economy.

"We now have a head start on economic recovery because at level one we become one of the most open, if not the most open, economies in the world," she said.

The prime minister said modelling showed the economy would operate at just 3.8 percent below normal at Level 1, compared with a 37 percent impairment at Level 4 lockdown.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
May 19,2020

May 19: A Chinese laboratory has been developing a drug it believes has the power to bring the coronavirus pandemic to a halt.

The outbreak first emerged in China late last year before spreading across the world, prompting an international race to find treatments and vaccines.

A drug being tested by scientists at China's prestigious Peking University could not only shorten the recovery time for those infected, but even offer short-term immunity from the virus, researchers say.

Sunney Xie, director of the university's Beijing Advanced Innovation Center for Genomics, told AFP that the drug has been successful at the animal testing stage.

"When we injected neutralising antibodies into infected mice, after five days the viral load was reduced by a factor of 2,500," said Xie.

"That means this potential drug has (a) therapeutic effect."

The drug uses neutralising antibodies -- produced by the human immune system to prevent the virus infecting cells -- which Xie's team isolated from the blood of 60 recovered patients.

A study on the team's research, published Sunday in the scientific journal Cell, suggests that using the antibodies provides a potential "cure" for the disease and shortens recovery time.

Xie said his team had been working "day and night" searching for the antibody.

"Our expertise is single-cell genomics rather than immunology or virology. When we realised that the single-cell genomic approach can effectively find the neutralising antibody we were thrilled."

He added that the drug should be ready for use later this year and in time for any potential winter outbreak of the virus, which has infected 4.8 million people around the world and killed more than 315,000.

"Planning for the clinical trial is underway," said Xie, adding it will be carried out in Australia and other countries since cases have dwindled in China, offering fewer human guinea pigs for testing.

"The hope is these neutralised antibodies can become a specialised drug that would stop the pandemic," he said.

China already has five potential coronavirus vaccines at the human trial stage, a health official said last week.

But the World Health Organization has warned that developing a vaccine could take 12 to 18 months.

Scientists have also pointed to the potential benefits of plasma -- a blood fluid -- from recovered individuals who have developed antibodies to the virus enabling the body's defences to attack it.

More than 700 patients have received plasma therapy in China, a process which authorities said showed "very good therapeutic effects".

"However, it (plasma) is limited in supply," Xie said, noting that the 14 neutralising antibodies used in their drug could be put into mass production quickly.

Using antibodies in drug treatments is not a new approach, and it has been successful in treating several other viruses such as HIV, Ebola and Middle East Respiratory Syndrome (MERS).

Xie said his researchers had "an early start" since the outbreak started in China before spreading to other countries.

Ebola drug Remdesivir was considered a hopeful early treatment for COVID-19 -- clinical trials in the US showed it shortened the recovery time in some patients by a third -- but the difference in mortality rate was not significant.

The new drug could even offer short-term protection against the virus.

The study showed that if the neutralising antibody was injected before the mice were infected with the virus, the mice stayed free of infection and no virus was detected.

This may offer temporary protection for medical workers for a few weeks, which Xie said they are hoping to "extend to a few months".

More than 100 vaccines for COVID-19 are in the works globally, but as the process of vaccine development is more demanding, Xie is hoping that the new drug could be a faster and more efficient way to stop the global march of the coronavirus.

"We would be able to stop the pandemic with an effective drug, even without a vaccine," he said.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.